List of Tables
Table 1. Anthrax Vaccines Market Trends
Table 2. Anthrax Vaccines Market Drivers & Opportunity
Table 3. Anthrax Vaccines Market Challenges
Table 4. Anthrax Vaccines Market Restraints
Table 5. Global Anthrax Vaccines Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Anthrax Vaccines Revenue Market Share by Company (2019-2024)
Table 7. Global Anthrax Vaccines Sales Volume by Company (2019-2024) & (M Doses)
Table 8. Global Anthrax Vaccines Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Anthrax Vaccines Price by Company (2019-2024) & (USD/Dose)
Table 10. Key Manufacturers Anthrax Vaccines Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Anthrax Vaccines Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Anthrax Vaccines
Table 13. Global Anthrax Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anthrax Vaccines as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Anthrax Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Anthrax Vaccines Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Anthrax Vaccines Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Anthrax Vaccines Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Anthrax Vaccines Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Anthrax Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (M Doses)
Table 22. Global Anthrax Vaccines Sales Volume by Type (2019-2024) & (M Doses)
Table 23. Global Anthrax Vaccines Sales Volume by Type (2025-2030) & (M Doses)
Table 24. Global Anthrax Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Anthrax Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Anthrax Vaccines Price by Type (2019-2024) & (USD/Dose)
Table 27. Global Anthrax Vaccines Price by Type (2025-2030) & (USD/Dose)
Table 28. Global Anthrax Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Anthrax Vaccines Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Anthrax Vaccines Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Anthrax Vaccines Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Anthrax Vaccines Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Anthrax Vaccines Sales Volume by Application: 2019 VS 2023 VS 2030 (M Doses)
Table 34. Global Anthrax Vaccines Sales Volume by Application (2019-2024) & (M Doses)
Table 35. Global Anthrax Vaccines Sales Volume by Application (2025-2030) & (M Doses)
Table 36. Global Anthrax Vaccines Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Anthrax Vaccines Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Anthrax Vaccines Price by Application (2019-2024) & (USD/Dose)
Table 39. Global Anthrax Vaccines Price by Application (2025-2030) & (USD/Dose)
Table 40. Global Anthrax Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Anthrax Vaccines Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Anthrax Vaccines Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Anthrax Vaccines Sales Value by Region (2019-2024) & (%)
Table 44. Global Anthrax Vaccines Sales Value by Region (2025-2030) & (%)
Table 45. Global Anthrax Vaccines Sales Volume by Region (M Doses): 2019 VS 2023 VS 2030
Table 46. Global Anthrax Vaccines Sales Volume by Region (2019-2024) & (M Doses)
Table 47. Global Anthrax Vaccines Sales Volume by Region (2025-2030) & (M Doses)
Table 48. Global Anthrax Vaccines Sales Volume by Region (2019-2024) & (%)
Table 49. Global Anthrax Vaccines Sales Volume by Region (2025-2030) & (%)
Table 50. Global Anthrax Vaccines Average Price by Region (2019-2024) & (USD/Dose)
Table 51. Global Anthrax Vaccines Average Price by Region (2025-2030) & (USD/Dose)
Table 52. Key Countries/Regions Anthrax Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Anthrax Vaccines Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Anthrax Vaccines Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Anthrax Vaccines Sales Volume, (2019-2024) & (M Doses)
Table 56. Key Countries/Regions Anthrax Vaccines Sales Volume, (2025-2030) & (M Doses)
Table 57. Emergent BioSolutions Company Information
Table 58. Emergent BioSolutions Introduction and Business Overview
Table 59. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 60. Emergent BioSolutions Anthrax Vaccines Product Offerings
Table 61. Emergent BioSolutions Recent Development
Table 62. Merial Company Information
Table 63. Merial Introduction and Business Overview
Table 64. Merial Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 65. Merial Anthrax Vaccines Product Offerings
Table 66. Merial Recent Development
Table 67. Merck Company Information
Table 68. Merck Introduction and Business Overview
Table 69. Merck Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 70. Merck Anthrax Vaccines Product Offerings
Table 71. Merck Recent Development
Table 72. Zoetis Company Information
Table 73. Zoetis Introduction and Business Overview
Table 74. Zoetis Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 75. Zoetis Anthrax Vaccines Product Offerings
Table 76. Zoetis Recent Development
Table 77. Bayer Sanidad Animal Company Information
Table 78. Bayer Sanidad Animal Introduction and Business Overview
Table 79. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 80. Bayer Sanidad Animal Anthrax Vaccines Product Offerings
Table 81. Bayer Sanidad Animal Recent Development
Table 82. Colorado Serum Company Information
Table 83. Colorado Serum Introduction and Business Overview
Table 84. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 85. Colorado Serum Anthrax Vaccines Product Offerings
Table 86. Colorado Serum Recent Development
Table 87. PharmAthene Company Information
Table 88. PharmAthene Introduction and Business Overview
Table 89. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 90. PharmAthene Anthrax Vaccines Product Offerings
Table 91. PharmAthene Recent Development
Table 92. Tiankang Company Information
Table 93. Tiankang Introduction and Business Overview
Table 94. Tiankang Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 95. Tiankang Anthrax Vaccines Product Offerings
Table 96. Tiankang Recent Development
Table 97. Biogénesis-Bago Company Information
Table 98. Biogénesis-Bago Introduction and Business Overview
Table 99. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 100. Biogénesis-Bago Anthrax Vaccines Product Offerings
Table 101. Biogénesis-Bago Recent Development
Table 102. CAVAC Company Information
Table 103. CAVAC Introduction and Business Overview
Table 104. CAVAC Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 105. CAVAC Anthrax Vaccines Product Offerings
Table 106. CAVAC Recent Development
Table 107. Rosenbusch Company Information
Table 108. Rosenbusch Introduction and Business Overview
Table 109. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 110. Rosenbusch Anthrax Vaccines Product Offerings
Table 111. Rosenbusch Recent Development
Table 112. Agrovet Company Information
Table 113. Agrovet Introduction and Business Overview
Table 114. Agrovet Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 115. Agrovet Anthrax Vaccines Product Offerings
Table 116. Agrovet Recent Development
Table 117. Vecol Company Information
Table 118. Vecol Introduction and Business Overview
Table 119. Vecol Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 120. Vecol Anthrax Vaccines Product Offerings
Table 121. Vecol Recent Development
Table 122. CVCRI Company Information
Table 123. CVCRI Introduction and Business Overview
Table 124. CVCRI Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 125. CVCRI Anthrax Vaccines Product Offerings
Table 126. CVCRI Recent Development
Table 127. IVPM Company Information
Table 128. IVPM Introduction and Business Overview
Table 129. IVPM Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 130. IVPM Anthrax Vaccines Product Offerings
Table 131. IVPM Recent Development
Table 132. Prondil Company Information
Table 133. Prondil Introduction and Business Overview
Table 134. Prondil Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 135. Prondil Anthrax Vaccines Product Offerings
Table 136. Prondil Recent Development
Table 137. CDV Company Information
Table 138. CDV Introduction and Business Overview
Table 139. CDV Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 140. CDV Anthrax Vaccines Product Offerings
Table 141. CDV Recent Development
Table 142. Indian Immunologicals Company Information
Table 143. Indian Immunologicals Introduction and Business Overview
Table 144. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 145. Indian Immunologicals Anthrax Vaccines Product Offerings
Table 146. Indian Immunologicals Recent Development
Table 147. Botswana Vaccine Institute Company Information
Table 148. Botswana Vaccine Institute Introduction and Business Overview
Table 149. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 150. Botswana Vaccine Institute Anthrax Vaccines Product Offerings
Table 151. Botswana Vaccine Institute Recent Development
Table 152. Ceva Santé Animale Company Information
Table 153. Ceva Santé Animale Introduction and Business Overview
Table 154. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 155. Ceva Santé Animale Anthrax Vaccines Product Offerings
Table 156. Ceva Santé Animale Recent Development
Table 157. Intervac Company Information
Table 158. Intervac Introduction and Business Overview
Table 159. Intervac Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 160. Intervac Anthrax Vaccines Product Offerings
Table 161. Intervac Recent Development
Table 162. JOVAC Company Information
Table 163. JOVAC Introduction and Business Overview
Table 164. JOVAC Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 165. JOVAC Anthrax Vaccines Product Offerings
Table 166. JOVAC Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Anthrax Vaccines Downstream Customers
Table 170. Anthrax Vaccines Distributors List
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Anthrax Vaccines Product Picture
Figure 2. Global Anthrax Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Anthrax Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Anthrax Vaccines Sales Volume (2019-2030) & (M Doses)
Figure 5. Global Anthrax Vaccines Sales Price (2019-2030) & (USD/Dose)
Figure 6. Anthrax Vaccines Report Years Considered
Figure 7. Global Anthrax Vaccines Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Anthrax Vaccines Players Sales Volume Ranking (2023) & (M Doses)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anthrax Vaccines Revenue in 2023
Figure 10. Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Live Vaccines Picture
Figure 12. Cell free PA Vaccines Picture
Figure 13. Global Anthrax Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Anthrax Vaccines Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Anthrax Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 16. Global Anthrax Vaccines Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Anthrax Vaccines Price by Type (2019-2030) & (USD/Dose)
Figure 18. Product Picture of Human Use
Figure 19. Product Picture of Animal Use
Figure 20. Global Anthrax Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Anthrax Vaccines Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Anthrax Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 23. Global Anthrax Vaccines Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Anthrax Vaccines Price by Application (2019-2030) & (USD/Dose)
Figure 25. North America Anthrax Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Anthrax Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Anthrax Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Anthrax Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Anthrax Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Anthrax Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Anthrax Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Anthrax Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Anthrax Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Anthrax Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Anthrax Vaccines Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Anthrax Vaccines Sales Volume (%), (2019-2030)
Figure 37. United States Anthrax Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Anthrax Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Anthrax Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Anthrax Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Anthrax Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Anthrax Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 43. China Anthrax Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Anthrax Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 45. China Anthrax Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Anthrax Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Anthrax Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Anthrax Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Anthrax Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Anthrax Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Anthrax Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Anthrax Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Anthrax Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Anthrax Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 55. India Anthrax Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Anthrax Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 57. India Anthrax Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 58. Anthrax Vaccines Industrial Chain
Figure 59. Anthrax Vaccines Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
